Linezolid USP Related Compound B;N-({(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidi n-5-yl}methyl)ethanethioamide;N-[[(5S)-3-[3-Fluoro-4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]Methyl]-ethane thioaMide;Deacetyl Linezolid Thioacetamide;(S)-N-{[3-(3-Fluoro-4-Morpholinophenyl)-2-oxooxazolidin-5-yl]Methyl}thioacetaMide;Linezolid Related CoMpound B;Linezolid Related Compound B (20 mg) ((S)-N-{[3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl}thioacetamide);Ethanethioamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-
For laboratory research purposes.Not for drug or household use.
信号词
Warning
InChIKey
ARKKSPJWSZIEQK-ZDUSSCGKSA-N
危险类别(旧)
H302,H315,H319,H335
存储要求
Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage.
安全信息
危险品分类
Acute toxicity, oral(Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation(Category 2A),Specific target organ toxicity, single exposure;Respiratory system(Category 3)